Literature DB >> 1928085

Side effects of erythropoietin therapy.

W M Bennett1.   

Abstract

Recombinant erythropoietin is usually associated with marked improvement in physiological and psychological well-being. Adverse effects are unusual. In this report, the unusual occurrence of seizures, increased clotting, and influenza-like syndromes is reviewed. Emphasis is given to adverse effects noted in the few available placebo-controlled studies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928085

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

Review 1.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

Review 2.  Peripheral nerve injury and myelination: Potential therapeutic strategies.

Authors:  Max Modrak; M A Hassan Talukder; Khatuna Gurgenashvili; Mark Noble; John C Elfar
Journal:  J Neurosci Res       Date:  2019-10-13       Impact factor: 4.164

Review 3.  Erythropoietin molecules to treat acute ischemic stroke: a translational dilemma!

Authors:  Paul A Lapchak
Journal:  Expert Opin Investig Drugs       Date:  2010-10       Impact factor: 6.206

Review 4.  A risk-benefit assessment of epoetin in the management of anaemia associated with cancer.

Authors:  Y Beguin
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

Review 5.  Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.

Authors:  C J Dunn; A J Wagstaff
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.